검색어: bevacizumabo (리투아니아어 - 영어)

1 ml yra 25 mg bevacizumabo.
bevacizumab 25 mg per ml.

bevacizumabo ir sunitinibo malato derinys
combination of bevacizumab and sunitinib malate

kiekviename buteliuke yra 100 mg bevacizumabo.
each vial contains 100 mg bevacizumab.

priešnavikinių preparatų poveikis bevacizumabo farmakokinetikai
effect of antineoplastic agents on bevacizumab pharmacokinetics

jo sudtyje yra veikliosios medziagos bevacizumabo.
it contains the active substance bevacizumab.

bevacizumabo poveikis kitų priešnavikinių preparatų farmakokinetikai
effect of bevacizumab on the pharmacokinetics of other antineoplastic agents

bevacizumabo mutageninis ir kancerogeninis poveikis netirtas.
studies to evaluate the mutagenic and carcinogenic potential of bevacizumab have not been performed.

5 bevacizumabo poveikis kit priesnavikini preparat farmakokinetikai
effect of bevacizumab on the pharmacokinetics of other antineoplastic agents

visų klinikinių tyrimų metu bevacizumabo lašinta į veną.
in all clinical trials, bevacizumab was administered as an iv infusion.

ar bevacizumabo patenka į moters pieną, nežinoma.
it is not known whether bevacizumab is excreted in human milk.

kiekviename 16 ml tūrio flakone yra 400 mg bevacizumabo.
each 16 ml vial contains 400 mg of bevacizumab.

bevacizumabo farmakokinetika tirta nedidelio skaiciaus serganci vaik organizme.
the pharmacokinetics of bevacizumab have been studied in a limited number of paediatric patients.

bevacizumabo farmakokinetika tirta nedidelio skaičiaus sergančių vaikų organizme.
the pharmacokinetics of bevacizumab have been studied in a limited number of paediatric patients.

galutinė bevacizumabo koncentracija turi būti 1, 4- 16, 5 mg/ ml.
the concentration of the final bevacizumab solution should be kept within the range of 1.4-16.5 mg/ ml.

oksaliplatina paremtos chemoterapijos metu 373 pacientai (30,4%) kartu vartojo bevacizumabo.
oxaliplatin-based regimens were administered in combination with bevacizumab in 373 patients (30.4%).

avastin 25 mg/ml koncentratas infuziniam tirpalui bevacizumabas
avastin 25 mg/ml concentrate for solution for infusion bevacizumab